🔎 Trials Near Me

Home › Atherosclerosis › Alabama › Huntsville

Atherosclerosis clinical trials in Huntsville, AL

5 studies for Atherosclerosis are looking for participants at sites in and around Huntsville (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

RecruitingPhase 2
  • Heart Center Research, LLC, Huntsville
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07783802

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RecruitingPhase 3
  • Heart Center Research LLC, Huntsville
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

RecruitingPhase 2
  • Heart Center Research, LLC, Huntsville
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07521007

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

RecruitingPhase 2/3
  • Nephrology Consultants, LLC, Huntsville
  • Nephrology of North Alabama, Decatur · 24 mi away
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

RecruitingPhase 3
  • Research Site, Huntsville
  • Research Site, Athens · 22 mi away
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

About Atherosclerosis

Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.

More about Atherosclerosis on MedlinePlus

Atherosclerosis trials in other cities

Other studies in Huntsville

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.